TFA Therapeutics, Inc. SEC filings RAJAF
TFA Therapeutics, Inc. has 38 filings in SEC EDGAR's recent list, going back to Dec 6, 2021. Its latest annual report, Form 20-F, was filed on May 15, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 2, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B4 | Prospectus | Mar 30, 2023 | — |
| F-1/A | Registration statement | Mar 20, 2023 | — |
| F-1/A | Registration statement | Mar 6, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Jan 20, 2023 | — |
Showing 4 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- RAJAF (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Taipei City
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1885680
- Former names
- Cordyceps Sunshine Biotech Holdings Co., Ltd. (until Jun 25, 2026)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.